What's new

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised

Feb 19, 2025 - 15:16
 0
Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Date of authorisation: 19/09/2024, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

nTop announces acquisition of computational fluid dynamics company cloudfluid

Next Article

Florida system taps new CFO

Related Posts

Methodology Working Party

Methodology Working Party

Feb 9, 2025  0

Orphan designation: Adeno-associated virus serotype 9 containing the human RPE65 gene inherited retinal dystrophy due to defects in the RPE65 gene, 16/01/2025 Positive

Orphan designation: Adeno-associated virus serotype 9 c...

Feb 24, 2025  0

EMA workshop on the challenges in drug development, regulation and clinical practice for immunoglobulins, Online, European Medicines Agency, Amsterdam, the Netherlands, from 5 March 2025, 14:00 (CET) to 5 March 2025, 18:00 (CET)

EMA workshop on the challenges in drug development, reg...

Feb 19, 2025  0